title: Detection of pregnancies with high risk of fetal macrosomia among women with gestational diabetes mellitus.
abstract: OBJECTIVE
  To compare the frequency of fetal macrosomia and Erb's palsy in two groups of women with gestational diabetes mellitus (GDM) and in healthy controls.
  
  
  METHODS
  Retrospective clinical study of women with GDM.
  
  
  METHODS
  Pregnant women in Greater Helsinki area.
  
  
  METHODS
  Nine hundred and five pregnancies and newborn infants of women with GDM and 805 non-diabetic controls.
  
  
  METHODS
  GDM was diagnosed by a 2-hour oral glucose tolerance test (OGTT) among women with risk factors for GDM. The treatment of GDM was resolved by a 24-hour glucose profile obtained after 2 or 3 abnormal glucose values in the OGTT. Patients with a history of insulin-treated GDM in a previous pregnancy and those with a fasting glucose over 6 mmol/l underwent a 24-h glucose profile directly without a preceding OGTT.
  
  
  METHODS
  Fetal macrosomia, defined as a birth weight (adjusted for sex and gestational age) of >2.0 SD above the mean of a Finnish standard population. Erb's palsy.
  
  
  RESULTS
  385 women (42.5%) were treated with insulin and diet and 520 (57.5%) with diet only. Macrosomia occurred more often in the insulin-treated group (18.2%, p<0.001) compared with the diet-treated group (4.4%) and the controls (2.2%). The rate of Erb's palsy was 2.7% in the insulin-treated group, 2.4% in the diet-treated group, compared with 0.3% in the controls (p<0.001).
  
  
  CONCLUSIONS
  The 24-hour glucose profile performed after the diagnosis of GDM clearly distinguishes between low-risk (diet-treated) and high-risk (insulin-treated) for fetal macrosomia in GDM pregnancies.
authors: Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. lauri.suhonen@hus.fi
authors: Lauri
authors: L
authors: Suhonen
authors: Vilho
authors: V
authors: Hiilesmaa
authors: Risto
authors: R
authors: Kaaja
authors: Kari
authors: K
authors: Teramo
mesh_terms: D000328:Adult; D001724:Birth Weight; D020516:Brachial Plexus Neuropathies / Q000453:epidemiology*; D016022:Case-Control Studies; D016640:Diabetes, Gestational / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D005320:Fetal Macrosomia / Q000453:epidemiology*; D005387:Finland / Q000453:epidemiology; D005951:Glucose Tolerance Test; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage; D016015:Logistic Models; D008297:Male; D011247:Pregnancy; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D007328:Insulin